FR2401913A1 - Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant - Google Patents

Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant

Info

Publication number
FR2401913A1
FR2401913A1 FR7826195A FR7826195A FR2401913A1 FR 2401913 A1 FR2401913 A1 FR 2401913A1 FR 7826195 A FR7826195 A FR 7826195A FR 7826195 A FR7826195 A FR 7826195A FR 2401913 A1 FR2401913 A1 FR 2401913A1
Authority
FR
France
Prior art keywords
azacycloalcanes
substitute
hydroxy
phenyl
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7826195A
Other languages
English (en)
Other versions
FR2401913B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2401913A1 publication Critical patent/FR2401913A1/fr
Application granted granted Critical
Publication of FR2401913B1 publication Critical patent/FR2401913B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Abstract

L'invention a trait au domaine de la chimie médicale. Elle concerne de nouveaux azacycloalcanes et leurs dérivés, y compris des analogues insaturés, chacun portant en position 3 un groupe 2-hydroxyphényle substitué en position 4 par un radical alkyle qui peut porter un atome d'oxygène, faisant partie de sa chaîne ou un groupe aralkyle qui peut porter un atome d'oxygène comme partie de sa chaîne alkylique. Les composés de l'invention agissent sur le système nerveux central; ils sont notamment doues de propriétés analgésiques.
FR7826195A 1977-09-13 1978-09-12 Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant Granted FR2401913A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/832,869 US4147872A (en) 1977-09-13 1977-09-13 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Publications (2)

Publication Number Publication Date
FR2401913A1 true FR2401913A1 (fr) 1979-03-30
FR2401913B1 FR2401913B1 (fr) 1983-01-21

Family

ID=25262819

Family Applications (4)

Application Number Title Priority Date Filing Date
FR7826195A Granted FR2401913A1 (fr) 1977-09-13 1978-09-12 Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant
FR7905183A Granted FR2412531A1 (fr) 1977-09-13 1979-02-28 Nouveaux 3-(2-hydroxy-4-(substituant)-phenyl)-azacycloalcanones
FR7905184A Granted FR2412530A1 (fr) 1977-09-13 1979-02-28 Nouveaux 3-(2'-hydroxy-4'(substituant)-phenyl)-4-alkylidene ou 4-phenylalkylidene-azacycloalcanes
FR7905185A Granted FR2412529A1 (fr) 1977-09-13 1979-02-28 Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcane-4-ols

Family Applications After (3)

Application Number Title Priority Date Filing Date
FR7905183A Granted FR2412531A1 (fr) 1977-09-13 1979-02-28 Nouveaux 3-(2-hydroxy-4-(substituant)-phenyl)-azacycloalcanones
FR7905184A Granted FR2412530A1 (fr) 1977-09-13 1979-02-28 Nouveaux 3-(2'-hydroxy-4'(substituant)-phenyl)-4-alkylidene ou 4-phenylalkylidene-azacycloalcanes
FR7905185A Granted FR2412529A1 (fr) 1977-09-13 1979-02-28 Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcane-4-ols

Country Status (23)

Country Link
US (1) US4147872A (fr)
JP (5) JPS5935397B2 (fr)
AR (2) AR222019A1 (fr)
AT (1) AT368753B (fr)
AU (1) AU507953B1 (fr)
BE (1) BE870403A (fr)
CA (1) CA1113463A (fr)
CH (1) CH638187A5 (fr)
DE (1) DE2839883A1 (fr)
DK (1) DK401078A (fr)
ES (2) ES473287A1 (fr)
FI (1) FI66173C (fr)
FR (4) FR2401913A1 (fr)
GB (1) GB2004548B (fr)
IE (1) IE47717B1 (fr)
IL (1) IL55555A (fr)
IT (1) IT1099026B (fr)
LU (1) LU80219A1 (fr)
NL (1) NL7809272A (fr)
PH (1) PH15372A (fr)
PT (1) PT68542A (fr)
SE (2) SE7809606L (fr)
YU (1) YU215678A (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
FI792076A (fi) * 1978-07-05 1980-01-06 Ciba Geigy Ag Foerfarande foer framstaellning av nya fenylpiperidinderivat
US4302590A (en) * 1979-02-23 1981-11-24 Hoechst-Roussel Pharmaceuticals, Inc. Intermediates for the preparation of 4-aryloxy-3-phenylpiperidines
US4312876A (en) * 1979-02-23 1982-01-26 Hoechst-Roussel Pharmaceuticals Incorporated Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
ZA821888B (en) * 1981-04-01 1983-02-23 Haessle Ab Novel phenyl-piperidines
US4709016A (en) * 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4529732A (en) * 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2003265659A1 (en) * 2002-08-23 2004-03-11 University Of Connecticut Novel biphenyl and biphenyl-like cannabinoids
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
WO2010095940A2 (fr) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Sustème d'administration de médicament à base de glutathionne
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
BR112015019208A2 (pt) * 2013-02-14 2017-07-18 Galderma Res & Dev processo de síntese

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310761A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et application a titre de medicaments

Also Published As

Publication number Publication date
US4147872A (en) 1979-04-03
FR2401913B1 (fr) 1983-01-21
FR2412530A1 (fr) 1979-07-20
PT68542A (en) 1978-10-01
LU80219A1 (fr) 1980-04-21
FR2412531A1 (fr) 1979-07-20
JPS5935397B2 (ja) 1984-08-28
FR2412530B1 (fr) 1982-11-12
IL55555A (en) 1982-08-31
IE781837L (en) 1979-03-13
AR220567A1 (es) 1980-11-14
AU507953B1 (en) 1980-03-06
YU215678A (en) 1983-06-30
IE47717B1 (en) 1984-05-30
ATA658078A (de) 1982-03-15
SE7809606L (sv) 1979-03-14
FR2412531B1 (fr) 1983-01-14
DK401078A (da) 1979-03-14
PH15372A (en) 1982-12-10
SE8305422L (sv) 1983-10-03
AT368753B (de) 1982-11-10
FR2412529A1 (fr) 1979-07-20
JPS5492973A (en) 1979-07-23
BE870403A (fr) 1979-03-12
JPS5538366A (en) 1980-03-17
JPS5495577A (en) 1979-07-28
JPS5538365A (en) 1980-03-17
NL7809272A (nl) 1979-03-15
GB2004548A (en) 1979-04-04
FR2412529B1 (fr) 1983-01-14
FI66173B (fi) 1984-05-31
GB2004548B (en) 1982-03-24
JPS5463086A (en) 1979-05-21
FI66173C (fi) 1984-09-10
AR222019A1 (es) 1981-04-15
CA1113463A (fr) 1981-12-01
ES473287A1 (es) 1980-03-01
IT7827557A0 (it) 1978-09-12
IL55555A0 (en) 1978-12-17
CH638187A5 (fr) 1983-09-15
JPS5640155B2 (fr) 1981-09-18
IT1099026B (it) 1985-09-18
ES480151A1 (es) 1980-04-01
FI782793A (fi) 1979-03-14
DE2839883A1 (de) 1979-03-15
SE8305422D0 (sv) 1983-10-03

Similar Documents

Publication Publication Date Title
FR2401913A1 (fr) Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
DE69023934T2 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
TNSN86111A1 (fr) Procede de preparation d'hydroxyalkylxanthines tertiaires
FR2421174A1 (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leurs applications en therapeutique
ATE198891T1 (de) Thienobenzodiazepinderivate zur behandlung von störungen des zentralnervensystems
FR2402639A1 (fr) Cycloalcanones et cycloalcanols substitues en position 3 par un groupe 2-hydroxyphenyle substitue en position 4 et composition pharmaceutique les contenant
FR2379553A1 (fr) Nouveaux photoinducteurs de polymerisation, compositions photopolymerisables les contenant et procede de photopolymerisation
MX20132A (es) Procedimiento para la preparacion de analogos de la prostaglandin amida, heterociclicos, substituidos con interfenilen 7-oxabicicloheptilo.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
ATE60579T1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
OA09016A (fr) Produits cathartiques.
FR2383907A1 (fr) Procede de preparation de derives de l'acide acetique et derives obtenus par ce procede
BE901229A (fr) Derive nouveau de diamide d'amino-acide a caractere acide n-acylique, un sel de celui-ci, un procede de production de celui-ci et un agent anti-ulcereux le contenant.
FR2429793A1 (fr) Nouveaux derives de purine et medicament les contenant
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
ATE266663T1 (de) Acrylamid-derivate und verfahren zu deren herstellung
FR2401916A1 (fr) Nouveaux derives de 5-hydroxy-1h-imidazole-4-carboxamide substitues en position 2, leur procede de production et composition pharmaceutique les contenant
TNSN86144A1 (fr) Procede pour la preparation de derives de la flavone
BR8607124A (pt) Um metodo de aumentar a excrecao de adenosina
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2446819A1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
ATE78824T1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
FR2361346A1 (fr) Dipeptides utiles comme medicaments
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant

Legal Events

Date Code Title Description
ST Notification of lapse